It's because of the phasing of the MEND trial (see below)
The 6 patients at the later time points are from the "low dose" Cohort 1 which started first. The data out there is a bit messy likely because of the smaller patient numbers and minimally effective dose level.
When Cohort 1 and the "high dose" Cohort 2 were separated out, the effect of the higher dose (which is what will be used in the STRIKE study) becomes more obvious and compelling.
It's because of the phasing of the MEND trial (see below)The 6...
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |